| MS Forum/MS Over the Past 17 Years. | |
| | |
MedLine Citation:
|
PMID: 21689489 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
At its final meeting, the MS Forum Executive Committee reviewed highlights of where things stood prior to the immunomodulatory era, and how things have evolved subsequently. What the future might hold was discussed in a second session. Prior to 1990: Genetic predisposition to multiple sclerosis (MS), as determined by human leukocyte antigen expression, was established and an environmental trigger (Epstein-Barr virus?) was suspected, as was lack of sunshine. Substantial evidence for activated T-cells as relapse initiators had accumulated. Defective regulatory cell function that correlated with disease activity was shown. Adrenocorticotropic hormone lessened relapse severity as did its steroid replacement. A trial of cyclosporine, a T-cell inhibitor, in progressive MS failed. The drug, not the patients chosen, was blamed. 1990-2010: Approval of interferon-beta (IFNB)-1b was followed promptly by IFNB-1a, glatiramer acetate, mitoxantrone and then by natalizumab and fingolimod. All reduce MS attack frequency and new lesion accumulation. None have reduced disability progression in progressive MS. Brain atrophy, cognitive loss and axonal interruption in progressive MS depend on innate immune system activation rather than on T-cells. New strategies are needed. |
| | |
Authors:
|
Bgw Arnason |
Related Documents
:
|
11823479 - Cutting edge: the toll pathway is required for resistance to gram-positive bacterial in... 17872459 - Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic ... 12860979 - The antifungal drug amphotericin b promotes inflammatory cytokine release by a toll-lik... 17885949 - Immune response to candida albicans is preserved despite defect in o-mannosylation of s... 19200169 - Role of tlr4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells. 18779779 - Critical role of the nadph oxidase subunit p47phox on vascular tlr expression and neoin... 8221019 - Free radicals in inflammation: second messengers and mediators of tissue destruction. 17617579 - Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elici... 10717099 - Biological response modifiers and normal tissue injury after irradiation. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International MS journal / MS Forum Volume: 17 ISSN: 1352-8963 ISO Abbreviation: Int MS J Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-06-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9804403 Medline TA: Int MS J Country: England |
Other Details:
|
Languages: eng Pagination: 76-82 Citation Subset: IM |
Affiliation:
|
Barry GW Arnason Department of Neurology Surgery Brain Research Institutes 5812 South Ellis Avenue SBRI J209 (MC 2030) Chicago, IL 60637 USA Tel: +1 773 702 6386 Fax: +1 773 702 9060 E-mail: barnason@neurology.bsd.uchicago.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Developments in MS over the Past 17 Years the MS Forum and The International MS Journal.
Next Document: 20th meeting of the European neurological society, 19-23 june 2010, berlin, Germany.